Hypermitotic meningiomas harbor DNA methylation subgroups with distinct biological and clinical features.
Sign Up to like & getrecommendations! Published in 2022 at "Neuro-oncology"
DOI: 10.1093/neuonc/noac224
Abstract: BACKGROUND Meningiomas, the most common primary intracranial tumors, can be separated into 3 DNA methylation groups with distinct biological drivers, clinical outcomes, and therapeutic vulnerabilities. Alternative meningioma grouping schemes using copy number variants, gene expression… read more here.
Keywords: methylation; dna methylation; distinct biological; hypermitotic meningiomas ... See more keywords